By making GLP-1 Companion free, Noom is giving clinicians a practical, research-backed resource they can recommend to patients at any point in the GLP-1 journey including before, during, and after medication
Considering Your Options: If you are still in the decision phase of your treatment plan, you may find it helpful to review a detailed comparison of bariatric surgery vs GLP-1 before getting started
Some women feel better as weight, sleep, and "food noise" improve
New research published in the Journal of the American Medical Association links Ozempic to gastroparesis, a chronic condition that severely weakens the muscles in the stomach wall, making it harder to push food over to the small intestine
High-throughput optical sensing of nucleic acids in a nanopore array
Retatrutide is an unlicensed investigational triple agonist (GLP-1, GIP, glucagon) with no MHRA or EMA marketing authorisation